HG-9-91-01

HG-9-91-01 

To Order Contact us: caitlyn@ucb-bioproducts.com

HG-10-102-01

B1262-10 10 mg
EUR 303
Description: HG-10-102-01 is a potent and selective inhibitor of leucine-rich repeat kinase 2 (LRRK2) with the IC50 values of 20.3nM and 3.2nM for wild type LRRK2 and LRRK2 [G1019S], respectively [1].

HG-10-102-01

B1262-5.1 10 mM (in 1mL DMSO)
EUR 192
Description: HG-10-102-01 is a potent and selective inhibitor of leucine-rich repeat kinase 2 (LRRK2) with the IC50 values of 20.3nM and 3.2nM for wild type LRRK2 and LRRK2 [G1019S], respectively [1].

HG-10-102-01

B1262-50 50 mg
EUR 821
Description: HG-10-102-01 is a potent and selective inhibitor of leucine-rich repeat kinase 2 (LRRK2) with the IC50 values of 20.3nM and 3.2nM for wild type LRRK2 and LRRK2 [G1019S], respectively [1].

HG-10-012-01

2604-25
EUR 577

HG-10-012-01

2604-5
EUR 185

1961358-01-9

TBW00991 5mg Ask for price

Chrysamine G *CAS 6472-91-9*

23055 5 mg
EUR 115

7095B 9 PASTEUR PIPET

7095B-9 200/pk
EUR 70
Description: Disposable Pipets; Pasteur Pipets

Individual Reaction Mix 9

G065-9 200 reactions
EUR 167

FGF-9 Recombinant Protein

91-178 0.05 mg
EUR 595.25
Description: Fibroblast Growth Factor 9 (FGF-9) belongs to the Fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF-9 plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. In addition, FGF-9 may have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors.

Siglec 9 Recombinant Protein

91-630 0.05 mg
EUR 490.25
Description: Sialic acid-binding Ig-like lectin 9(Siglec 9) is expressed by peripheral blood leukocytes (neutrophils and monocytes but not eosinophils), and found in liver, fetal liver, bone marrow, placenta, spleen and in lower levels in skeletal muscle, fetal brain and so on. It is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. It also binds to alpha-2,3- or alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.

IL-9 Recombinant Protein

91-728 0.05 mg
EUR 684.5
Description: Interleukin-9 (IL-9) is a secreted protein that belongs to the IL-7/IL-9 family. IL-9 supports IL-2 independent and IL-4 independent growth of helper T-cells. IL-9 stimulates cell proliferation and prevents apoptosis. It functions through the IL-9 receptor (IL-9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. IL-9 has been identified as a candidate gene for asthma. IL-9 is a determining factor in the pathogenesis of bronchial hyperresponsiveness.

Mercury(Hg)

AT013 1mg
EUR 1368

Chelant-Hg

AG013 1 mg
EUR 523

7095D 9 PASTEUR PIPET BOROSILICATE

7095D-9 200/pk
EUR 78
Description: Disposable Pipets; Pasteur Pipets

Proprotein Convertase 9 Recombinant Protein

91-780 0.05 mg
EUR 490.25
Description: Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER , the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2), and play a role in the neural development.

Proprotein Convertase 9 Recombinant Protein

91-783 0.05 mg
EUR 710.75
Description: Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER , the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis.PCSK9 also plays a role in neural development.

Proprotein Convertase 9 Recombinant Protein

91-785 0.05 mg
EUR 542.75
Description: Recombinant Human Proprotein Convertase Subtilisin/Kexin Type 9/PCSK9 (D374Y) is a gain of function mutant of human PCSK9 protein. Human PCSK9 is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER, the pro domain and mature chain are secreted together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and it plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2), and play a role in the neural development.

IITZ-01

HY-112897 25mg
EUR 533

TA-01

HY-100114 50mg
EUR 1042

UCN-01

U005-1MG 1 mg
EUR 355

UCN-01

U005-5MG 5 mg
EUR 1167

YM-01

20-abx076594
  • EUR 411.00
  • EUR 662.00
  • 10 mg
  • 25 mg

A83 01

20-abx076740
  • EUR 648.00
  • EUR 286.00
  • 25 mg
  • 5 mg

SL-01

abx076822-50mg 50 mg
EUR 272

OXA-01

C4204-10 10 mg
EUR 311
Description: OXA-01 is an ATP-competitive and selective inhibitor of both mTORC1 and mTORC2 with IC50 values of 29 nM and 7 nM, respectively [1]. The mammalian target of rapamycin (mTOR) is a serine/threonine kinase and exists in two complexes, mTORC1 and mTORC2.

OXA-01

C4204-25 25 mg
EUR 659
Description: OXA-01 is an ATP-competitive and selective inhibitor of both mTORC1 and mTORC2 with IC50 values of 29 nM and 7 nM, respectively [1]. The mammalian target of rapamycin (mTOR) is a serine/threonine kinase and exists in two complexes, mTORC1 and mTORC2.

OXA-01

C4204-5 5 mg
EUR 206
Description: OXA-01 is an ATP-competitive and selective inhibitor of both mTORC1 and mTORC2 with IC50 values of 29 nM and 7 nM, respectively [1]. The mammalian target of rapamycin (mTOR) is a serine/threonine kinase and exists in two complexes, mTORC1 and mTORC2.

TA 01

B4923-10 10 mg
EUR 216

TA 01

B4923-5.1 10 mM (in 1mL DMSO)
EUR 189

TA 01

B4923-50 50 mg
EUR 737

PG 01

B7545-10 10 mg
EUR 334

PG 01

B7545-50 50 mg
EUR 1243

UCN-01

C4783-1 1 mg
EUR 266

TA-01

B1214-25
EUR 566

TA-01

B1214-5
EUR 185

IITZ-01

B2378-1
EUR 131

IITZ-01

B2378-5
EUR 370

OXA-01

2695-25
EUR 588

OXA-01

2695-5
EUR 185

PS-beta-G-9 Recombinant Protein

91-792 0.05 mg
EUR 710.75
Description: Pregnancy-specific beta-1-glycoprotein 9(PSG9) is a secreted protein and contains 3 Ig-like C2-type (immunoglobulin-like) domains, 1 Ig-like V-type (immunoglobulin-like) domain. It is a member of the PSG family, a group of closely related secreted glycoproteins that are highly expressed in fetal placental syncytiotrophoblast cells. The members of the PSG protein family all have a characteristic N-terminal domain that is homologous to the immunoglobulin variable region. PSGs become detectable in serum during the first two to three weeks of pregnancy and increase as the pregnancy progresses, eventually representing the most abundant fetal protein in the maternal blood at term. PSGs function to stimulate secretion of TH2-type cytokines from monocytes, and they may also modulate the maternal immune system during pregnancy, thereby protecting the semi-allotypic fetus from rejection. PSGs are commonly expressed in trophoblast tumors. Eleven human PSG proteins (PSG1-PSG11) have been described.

ST 91

B7132-10 10 mg
EUR 292

ST 91

B7132-50 50 mg
EUR 1054

K 01-162

HY-14533 10mM/1mL
EUR 705

A 77-01

HY-78349 5mg
EUR 215

A 83-01

HY-10432 50mg
EUR 436

HTH-01-015

HY-12334 10mM/1mL
EUR 176

KX-01-191

HY-128721 50mg
EUR 1944

A 77-01

A3132-10 10 mg
EUR 168
Description: Transforming growth factor (TGF)-? signaling facilitates tumor growth and metastasis in advanced cancer. Use of inhibitors of TGF-? signaling may thus be a novel strategy for the treatment of patients with such cancer.

A 77-01

A3132-25 25 mg
EUR 267
Description: Transforming growth factor (TGF)-? signaling facilitates tumor growth and metastasis in advanced cancer. Use of inhibitors of TGF-? signaling may thus be a novel strategy for the treatment of patients with such cancer.

A 77-01

A3132-5.1 10 mM (in 1mL DMSO)
EUR 189
Description: Transforming growth factor (TGF)-? signaling facilitates tumor growth and metastasis in advanced cancer. Use of inhibitors of TGF-? signaling may thus be a novel strategy for the treatment of patients with such cancer.

A 83-01

A3133-10 10 mg
EUR 212
Description: A 83-01 is a small-molecule inhibitor of activin receptorlike kinase (ALK)-5 with IC50 value of 12 nM. A 83-01 inhibited 68% of the transcriptional activation induced by ALK-5 at concentration of 1 ?M in Mv1LuR4-2 cells that transfected with luciferase reporter gene and constitutively active ALK-5.

A 83-01

A3133-5.1 10 mM (in 1mL DMSO)
EUR 189
Description: A 83-01 is a small-molecule inhibitor of activin receptorlike kinase (ALK)-5 with IC50 value of 12 nM. A 83-01 inhibited 68% of the transcriptional activation induced by ALK-5 at concentration of 1 ?M in Mv1LuR4-2 cells that transfected with luciferase reporter gene and constitutively active ALK-5.

A 83-01

A3133-50 50 mg
EUR 519
Description: A 83-01 is a small-molecule inhibitor of activin receptorlike kinase (ALK)-5 with IC50 value of 12 nM. A 83-01 inhibited 68% of the transcriptional activation induced by ALK-5 at concentration of 1 ?M in Mv1LuR4-2 cells that transfected with luciferase reporter gene and constitutively active ALK-5.

HTH-01-015

A8890-10 10 mg
EUR 186
Description: HTH-01-015 is a highly specific inhibitor of NUAK1 with IC50 value of 100 nM 1.HTH-01-015 showed extreme selectivity. It only inhibited the NUAK1 (NUAK family SNF1-like kinase-1) isoform of NUAK kinases and showed no significant inhibition of 139 other tested kinases.

HTH-01-015

A8890-200 200 mg
EUR 789
Description: HTH-01-015 is a highly specific inhibitor of NUAK1 with IC50 value of 100 nM 1.HTH-01-015 showed extreme selectivity. It only inhibited the NUAK1 (NUAK family SNF1-like kinase-1) isoform of NUAK kinases and showed no significant inhibition of 139 other tested kinases.

HTH-01-015

A8890-5.1 10 mM (in 1mL DMSO)
EUR 177
Description: HTH-01-015 is a highly specific inhibitor of NUAK1 with IC50 value of 100 nM 1.HTH-01-015 showed extreme selectivity. It only inhibited the NUAK1 (NUAK family SNF1-like kinase-1) isoform of NUAK kinases and showed no significant inhibition of 139 other tested kinases.

HTH-01-015

A8890-50 50 mg
EUR 464
Description: HTH-01-015 is a highly specific inhibitor of NUAK1 with IC50 value of 100 nM 1.HTH-01-015 showed extreme selectivity. It only inhibited the NUAK1 (NUAK family SNF1-like kinase-1) isoform of NUAK kinases and showed no significant inhibition of 139 other tested kinases.

Ro 01-6128

B7654-10 10 mg
EUR 192

Ro 01-6128

B7654-5 5 mg
EUR 139

A 83-01

1725-1
EUR 175

HTH-01-015

2887-25
EUR 756

HTH-01-015

2887-5
EUR 229

Human Brain Tissue Preparation Buffer 9: Normal Nerve Microglia

9-80021 1 x 100 ml Ask for price

Human Cancer Tissue Preparation Buffer 9: Kidney Tumor Cells

9-80032 1 x 100 ml Ask for price

Mouse Brain Tissue Preparation Buffer 9: Normal Nerve Microglia

9-80132 1 x 100 ml Ask for price

Rat Brain Tissue Preparation Buffer 9: Normal Neuron Cells

9-80227 1 x 100 ml Ask for price

COLLECTION CONTAINER 1L, EVA FILM

91-200-01 1/pk
EUR 80
Description: Flexible Containers; Bioprocess Bags and Parts

Monoclonal GFAP Antibody (clone GF-01), Clone: GF-01

APG03320G 0.05mg
EUR 484
Description: A Monoclonal antibody against Human GFAP (clone GF-01). The antibodies are raised in Mouse and are from clone GF-01. This antibody is applicable in WB and IHC-P, ICC, IP

HG-14-10-04

HY-15801 100mg
EUR 2943

TFMB-(R)-2-HG

HY-129079 10mM/1mL
EUR 233

Anserini HG ELISA Kit

EAH0248 96Tests
EUR 521

Rat HG ELISA Kit

ERH0248 96Tests
EUR 521

Rabbit HG ELISA Kit

ERTH0248 96Tests
EUR 521

Mouse HG ELISA Kit

EMH0248 96Tests
EUR 521

Porcine HG ELISA Kit

EPH0248 96Tests
EUR 521

Human HG ELISA Kit

EHH0248 96Tests
EUR 521

Canine HG ELISA Kit

ECH0248 96Tests
EUR 521

Bovine HG ELISA Kit

EBH0248 96Tests
EUR 521

Goat HG ELISA Kit

EGTH0248 96Tests
EUR 521

Human Angiotensin 1-9 (Ang1-9) ELISA Kit

RD-Ang1-9-Hu-48Tests 48 Tests
EUR 503

Human Angiotensin 1-9 (Ang1-9) ELISA Kit

RD-Ang1-9-Hu-96Tests 96 Tests
EUR 697

Human Angiotensin 1-9 (Ang1-9) ELISA Kit

DLR-Ang1-9-Hu-48T 48T
EUR 501
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Angiotensin 1-9 (Ang1-9) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Angiotensin 1-9 (Ang1-9) ELISA Kit

DLR-Ang1-9-Hu-96T 96T
EUR 651
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Angiotensin 1-9 (Ang1-9) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Angiotensin 1-9 (Ang1-9) ELISA Kit

RDR-Ang1-9-Hu-48Tests 48 Tests
EUR 525

Human Angiotensin 1-9 (Ang1-9) ELISA Kit

RDR-Ang1-9-Hu-96Tests 96 Tests
EUR 729

Monoclonal p56lck / LCK Antibody (clone Lck-01), Clone: Lck-01

APR17729G 0.05mg
EUR 484
Description: A Monoclonal antibody against Human p56lck / LCK (clone Lck-01). The antibodies are raised in Mouse and are from clone Lck-01. This antibody is applicable in WB and IHC-P, ICC, IP, Flo

YM-01 (Hsp70 Inhibitor)

SIH-121-10MG 10 mg
EUR 249
Description: The substance YM-01 is a hsp70 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is orange red solid which is soluble in warm water (2 mg/ml) .

YM-01 (Hsp70 Inhibitor)

SIH-121-25MG 25 mg
EUR 434
Description: The substance YM-01 is a hsp70 inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is orange red solid which is soluble in warm water (2 mg/ml) .

ZT-12-037-01

HY-122866 100mg
EUR 1175

112523-91-8

TBZ0271 unit Ask for price

Human Carbohydrate Antigen 19-9 (CA19-9) ELISA Kit

RD-CA19-9-Hu-48Tests 48 Tests
EUR 436

HG-9-91-01